Related Experiment Video

Updated: Sep 28, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

T2*-weighted MRI differentiates multiple system atrophy from Parkinson's disease

Eduard Kraft1, Claudia Trenkwalder, Dorothee P Auer

  • 1Max Planck-Institute of Psychiatry, Munich, Germany. eduard.kraft@medizin.uni-ulm.de

Neurology
|October 23, 2002
PubMed

Insights

T2*-weighted MRI scans can help differentiate multiple system atrophy (MSA) from Parkinson's disease (PD) by detecting specific signal changes in the putamen, aiding in parkinsonism diagnosis.

Area of Science:

  • Neuroimaging
  • Neurology
  • Radiology

Background:

  • Idiopathic Parkinson's disease (PD) and multiple system atrophy (MSA) are common neurodegenerative parkinsonism disorders.
  • Accurate differentiation between PD and MSA is crucial for appropriate patient management and treatment.
  • Distinguishing between these conditions based solely on clinical presentation can be challenging.

Purpose of the Study:

  • To evaluate the diagnostic utility of T2*-weighted gradient echo (GE) and T2-weighted fast spin echo (FSE) magnetic resonance imaging (MRI) sequences.
  • To determine if these MRI sequences can effectively differentiate between patients with idiopathic PD and probable MSA.

Main Methods:

  • The study included 15 patients with probable MSA, 40 patients with PD, and 17 healthy controls.
  • T2*-weighted GE and T2-weighted FSE MRI sequences were acquired for all participants.
  • Putaminal signal intensity was analyzed to identify hypointense changes.

Main Results:

  • Hypointense signal changes in the putamen were significantly more frequent in patients with MSA compared to those with PD.
  • These putaminal signal changes were detectable using T2*-weighted GE sequences.
  • T2-weighted FSE images did not show a significant difference in putaminal signal between MSA and PD groups.

Conclusions:

  • T2*-weighted GE MRI sequences demonstrate diagnostic value in distinguishing between MSA and PD.
  • The presence of putaminal hypointensity on T2*-weighted GE images is a key indicator for MSA in patients with parkinsonism.
  • These findings support the use of T2*-weighted GE MRI as a valuable tool in the differential diagnosis of parkinsonism.

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Neural Regulation01:47

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.